Skip to main content
A Family of four playing outdoors in the grass and sunshine

Healthier Communities

Focus Area Ambitions and Commitments 
Access and Affordability CSL’s ambition is to advance equitable access to its medicines and vaccines by designing programs around vulnerable populations and expanding strategic donations. Through extension of existing WFH partnership, by 2030, CSL aims to:

  • Enable 2,100 people with bleeding disorders to access prophylaxis therapy across 25 capable low and middle income countries.
Patient Experience CSL’s ambition is to elevate the Patient Experience in drug development by embedding patient insights and lived experience through patient-informed clinical development programs and formalising diversity plans to include representative populations.
CSL’s Goals for 2030:

  • Informed Product Development: ensure all of CSL’s therapeutic product development programs are informed by patient insights.
  • Diverse Clinical Trials: ensure Phase III clinical trials incorporate diversity that is representative of the target indicated population.
Donor Experience CSL’s ambition is to create best-in-class donor experience in partnership with donors and communities, by continuously innovating the donation process, supporting donors’ holistic well-being, and investing in the health equity of donor communities.
CSL’s initial goal for 2030 is to initiate new programs to promote health awareness resources, ensuring that at least 30% of donors gain access.
Furthermore, CSL intends to increase donor satisfaction survey results, utilising a new customer satisfaction methodology to be implemented and baselined in FY25.

CSL's Community Contributions Framework

Focus Area Focus Area Description Alignment with our Values and 2030 Strategy
Support for Patient Communities
  • Enhancing quality of life for patients in the conditions our therapies treat
  • Improving access to our medicines
  • Aligns with CSL’s Values of Patient Focus and Integrity.
  • Supports CSL’s Patient and Public Health and Focus strategic objectives by improving patient outcomes.
Support for Innovation and Science
  • Advancing knowledge in medical and scientific communities
  • Fostering the next generation of medical researchers
  • Aligns with CSL’s Values of Innovation and Collaboration.
  • Supports CSL’s Innovation strategic objective by fueling new breakthroughs, enhancing scientific knowledge and building capability and capacity.
Support for Local Communities
  • Supporting community efforts where we live and work
  • Supporting communities in times of emergency
  • Aligns with CSL’s Value of Superior Performance.
  • Supports CSL’s People and Culture strategic objective by creating an environment that employees feel proud to perform within.

Our approach to community contributions is guided by our Code of Responsible Business Practice and Global Community Contributions Policy. The policy applies to all CSL businesses and employees and is intended to be implemented across the businesses to guide decision-making and management of any form of community contribution, financial or by other means.